Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05267704 · ClinicalTrials.gov registry record · NA
Evaluating the Feasibility of VR for Pediatric Renal Biopsies
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT05267704 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 32 participants.
The verdict
NCT05267704, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the use of virtual reality (VR) as an adjunct or alternative to pharmacologic sedation in pediatric patients undergoing renal biopsy.
Interventions
- DEVICE Oculus Go Virtual Reality Headset
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2022-10-11 |
| Est. Completion | 2024-09-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05267704
The ClinicalTrials.gov registry entry for NCT05267704 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oculus Go Virtual Reality Headset is the first listed.
NCT05267704 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05267704 about?
NCT05267704 is a clinical study titled "Evaluating the Feasibility of VR for Pediatric Renal Biopsies". The purpose of this study is to assess the use of virtual reality (VR) as an adjunct or alternative to pharmacologic sedation in pediatric patients undergoing renal biopsy.
What is the current status of trial NCT05267704?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2022-10-11. Estimated completion is 2024-09-10.
What interventions are being tested in trial NCT05267704?
The interventions under investigation include: Oculus Go Virtual Reality Headset (DEVICE).
Who is sponsoring clinical trial NCT05267704?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.